Novo Nordisk A/S is a global healthcare company, which engages in the the
discovery, development, manufacturing and marketing of pharmaceutical products.
It operates through the Diabetes and Obesity Care, and Biopharm segments. The
Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery
systems, oral antidiabetic products (OAD), obesity, and other serious chronic
diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine
disorders, and hormone replacement therapy. The company was founded by Harald
Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsvaerd, Denmark.
